EUVIMEDEUVIMED entdecken
Crossref

Formulation and Evaluation of Modified Release Dosage Form of Finerenone

Sachin R. Choriya, Bhumi A. Raval, Jitendra O. Bhangale

International Journal of Drug Delivery Technology · 25.05.2026 · 16 (32s)

DOI: 10.25258/ijddt.16.32s.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.05.2026. Verfasst von Sachin R. Choriya und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: The present study aimed to formulate and evaluate sustained release matrix tablets of Finerenone for the management of chronic kidney disease associated with type 2 diabetes mellitus. Finerenone, a non-steroidal mineralocorticoid receptor antagonist, exhibits limited bioavailability due to first-pass metabolism. Matrix tablets were prepared using polymers such as Acrypol 912 and Acrypol 971 by wet granulation technique. A 3² factorial design was employed to optimize polymer concentration and evaluate its effect on drug release. Preformulation studies, including melting point (232–236°C), UV analysis (λmax 252 nm), and FTIR confirmed drug identity and compatibility. The prepared formulations were evaluated for pre-compression parameters and post-compression parameters such as hardness, friability, and drug content, all within acceptable limits. In vitro dissolution studies showed sustained drug release up to 24 hours. Among all formulations, batch FS9 demonstrated the most desirable release profile with controlled drug release and minimal burst effect. The optimized formulation exhibited good mechanical strength and stability under accelerated conditions. Thus, sustained release matrix tablets of Finerenone were successfully developed, offering improved therapeutic efficacy and patient compliance.

Zitieren

APA

Choriya, S. R., Raval, B. A., & Bhangale, J. O. (2026). Formulation and Evaluation of Modified Release Dosage Form of Finerenone. International Journal of Drug Delivery Technology, 16(32s). https://doi.org/10.25258/ijddt.16.32s.6

Vancouver

Choriya SR, Raval BA, Bhangale JO. Formulation and Evaluation of Modified Release Dosage Form of Finerenone. International Journal of Drug Delivery Technology. 2026;16(32s). doi:10.25258/ijddt.16.32s.6

BibTeX
@article{Choriya2026,
  author = {Choriya, Sachin R. and Raval, Bhumi A. and Bhangale, Jitendra O.},
  title = {Formulation and Evaluation of Modified Release Dosage Form of Finerenone},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {32s},
  doi = {10.25258/ijddt.16.32s.6}
}
Kostenlos starten →